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About three-quarters of human body surface is exposed to dense microbial population along the 
gastro-intestinal tract (GIT) that accommodates around 80% of immune cells. The GIT is one of the 
most critical sites for metabolic and immunologic homeostasis in the body. While large-scale 
genomic analysis and germ-free mice have been widely used, they are limited to capture the 
dynamic functional interaction between host-microbiome in a humanized setting. in-vitro 
recapitulation of GIT physiology can be a powerful alternative for hypothesis testing in diseases like 
IBD and cancer. 
As a first step, we developed a simple transwell assembly to closely emulate GIT anatomy and the 
barrier function in a quantitative and analytical manner. The system enables us to sequentially 
house bacterial cells, a mucus layer, human intestinal epithelial cells and human peripheral blood 
mononuclear cells (hPBMCs) in a single co-culture platform. Porcine intestine-derived mucin formed 
a biophysically relevant barrier and also provided in-vivo like biochemical milieu to bacterial cells. 
Addition of human epithelial cell monolayer on a collagen coated semi-permeable membrane added 
another level of cellular and biophysical complexity. Finally, by introducing human peripheral blood 
mononuclear cells (hPBMCs), we simulated host-microbiome interactions and successfully captured 
responses relevant to gut inflammation. Initial data indicate that bacterial products successfully 
stimulate hPBMCs. Whereas, mucus and epithelial barriers demonstrated strong 
immunomodulatory functions. Further investigations are being carried out in order to create models 
that will incorporate differentiated epithelial cells (villi), physiologically relevant flow and stress 
conditions along with co-culture of aerobic (mucosal) and anaerobic (luminal) components of the 
human GIT. Hopefully, these models will enable us to study mechanistic interactions of the 
microbiome with the host and reveal novel therapeutic targets for diseases associated with the 
dysregulation of host-microbiome homeostasis in human GIT. 
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